Teladoc Health (TDOC) has upgraded its 24/7 Care service by expanding virtual urgent care to cover more conditions, integrating specialist input, and supporting preventive care, even as investors weigh concerns about user trends and profitability.

These 24/7 Care upgrades arrive after a sharp reset in sentiment, with the 30 day share price return of Teladoc Health at an 11.93% decline and the 1 year total shareholder return at a 37.38% loss, suggesting momentum has been fading despite product progress and ongoing concerns about growth, profitability and financial risk.

If this kind of virtual care story has your attention, it could be a good moment to scan other healthcare stocks that might fit your watchlist next.

With Teladoc Health shares down sharply over 1, 3 and 5 years, yet trading at a 54% discount to an intrinsic estimate and 42% below analyst targets, is this punished virtual care name mispriced, or is the market correctly discounting its future growth?

Most Popular Narrative: 30.4% Undervalued

With Teladoc Health last closing at $6.35 against a narrative fair value of $9.13, the widely followed view points to a sizeable gap that hinges on long term chronic care and international growth assumptions.

The company's ongoing international expansion, with double digit growth in its international integrated care business and a focused rollout of localized services, diversifies revenue streams and accesses underserved markets, which is likely to drive sustainable topline and membership growth.

Curious what has to happen for that valuation to make sense? This narrative leans on modest revenue growth, a swing in margins and a lower future earnings multiple. The exact mix of those moving parts might surprise you.

Result: Fair Value of $9.13 (UNDERVALUED)

However, that gap relies on BetterHelp stabilising and chronic care contracts holding up. Any sustained churn or pricing pressure could quickly challenge this narrative.

Build Your Own Teladoc Health Narrative

If this consensus view does not sit right with you, or you prefer to rely on your own analysis, you can test different assumptions, stress test the numbers and build a custom Teladoc Health story in just a few minutes with Do it your way.

A great starting point for your Teladoc Health research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

If Teladoc sparks questions about where to look next, do not stop here. Use the screener to spot fresh opportunities that fit the themes you care about most.

• Hunt for potential turnaround names and higher risk reward setups through these 3526 penny stocks with strong financials that already clear basic financial filters.
• Zero in on the AI trend by scanning these 24 AI penny stocks that tie artificial intelligence to real business models instead of just buzzwords.
• Focus on value by checking these 879 undervalued stocks based on cash flows that appear inexpensive based on cash flows and could deserve a closer look on your watchlist.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.